Authors

• Ralph Graeser (ORCID: https://orcid.org/0000-0002-3600-2484)
• Ulrich Kunz
• Sina Pleiner
• Jack Beusmans
• Ulrike Schmid
• Girish Jayadeva
• Zohra Oum'Hamed
• Christophe Le Tourneau (ORCID: https://orcid.org/0000-0001-9772-4686)
• Doreen Luedtke
• Min He (ORCID: https://orcid.org/0000-0002-0862-8885)
• Xiaoning Wang (ORCID: https://orcid.org/0000-0002-7925-2774)
• Sascha Keller
• Heiko G. Niessen (ORCID: https://orcid.org/0000-0003-0188-3629)
• Martin Büchert

Institutions

• Boehringer Ingelheim (Germany) (DE)
• Inserm (FR)
• University of Freiburg (DE)
• Université Paris-Saclay (FR)
• University Medical Center Freiburg (DE)
• Pieris Pharmaceuticals (United States) (US)
• Metrum Research Group (United States) (US)
• Boehringer Ingelheim (France) (FR)
• Boehringer Ingelheim (United States) (US)
• Institut Curie (FR)

Publication Details

Journal

Journal of Translational Medicine

Published

2024-10-14

DOI

https://doi.org/10.1186/s12967-024-05612-x

Citations

2

Primary Topic

Angiogenesis and VEGF in Cancer

Type

article

Field-Weighted Citation Impact

0.47

Funders

• Boehringer Ingelheim
• Albert-Ludwigs-Universität Freiburg
• Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg